These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 10751238

  • 1. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education.
    Chan WB, Chan JC, Chow CC, Yeung VT, So WY, Li JK, Ko GT, Ma RC, Cockram CS.
    QJM; 2000 Mar; 93(3):183-90. PubMed ID: 10751238
    [Abstract] [Full Text] [Related]

  • 2. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function.
    McFarlane SI, Chaiken RL, Hirsch S, Harrington P, Lebovitz HE, Banerji MA.
    Diabet Med; 2001 Jan; 18(1):10-6. PubMed ID: 11168335
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Glycaemic control, disease duration and beta-cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project.
    Ostgren CJ, Lindblad U, Ranstam J, Melander A, Råstam L, Skaraborg hypertension and Diabetees Project.
    Diabet Med; 2002 Feb; 19(2):125-9. PubMed ID: 11874428
    [Abstract] [Full Text] [Related]

  • 7. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC.
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X, Deng H, Zhang X, Yang D, Yan J, Yao B, Weng J, Xu W.
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A, Frison V, Bettio M, Dal Pos M, Rocchini P, Panebianco G, Tadiotto F, Da Tos V, D'Ambrosio M, Marangoni A, Ferrari M, Pianta A, Balzano S, Confortin L, Lamonica M, Marin N, Strazzabosco M, Brun E, Mesturino CA, Simoncini M, Zen F, Bax G, Bonsembiante B, Cardone C, Dal Frà MG, Gallo A, Masin M, Piarulli F, Sartore G, Simioni N.
    Clin Ther; 2015 Mar 01; 37(3):574-84. PubMed ID: 25626486
    [Abstract] [Full Text] [Related]

  • 13. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ, Cano C, Medina MT, Souki A, Lemus MA, Leal EM, Seyfi HA, Cano R, Ciscek A, Bermúdez-Arias F, Contreras F, Israili ZH, Hernández-Hernández R, Valasco M.
    Am J Ther; 2007 Mar 01; 14(2):194-202. PubMed ID: 17414590
    [Abstract] [Full Text] [Related]

  • 14. Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project.
    Ostgren CJ, Lindblad U, Bøg-Hansen E, Ranstam J, Melander A, Råstam L.
    Diabetes Obes Metab; 1999 Mar 01; 1(2):105-12. PubMed ID: 11220508
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pancreatic beta cell function and antibodies to glutamic acid decarboxylase (anti-GAD) in Chinese patients with clinical diagnosis of insulin-dependent diabetes mellitus.
    Chan JC, Yeung VT, Chow CC, Ko GT, Mackay IR, Rowley MJ, Zimmet PZ, Cockram CS.
    Diabetes Res Clin Pract; 1996 Apr 01; 32(1-2):27-34. PubMed ID: 8803479
    [Abstract] [Full Text] [Related]

  • 18. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.
    Clin Ther; 2007 Nov 01; 29(11):2349-64. PubMed ID: 18158076
    [Abstract] [Full Text] [Related]

  • 19. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus.
    Kudolo GB.
    J Clin Pharmacol; 2001 Jun 01; 41(6):600-11. PubMed ID: 11402628
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.